Occult lead intoxication as a cause of hypertension and renal failure

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1775-1780

  Sanchez Fructuoso A I ^a   Torralbo, A ^a   Arroyo, M ^a   Luque, M ^a   Ruilope, L M ^b   Santos, J L ^a   Cruceyra, A ^a   Barrientos, A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Chronic renal failure; EDTA test; Gout; Hypertension; Lead nephrotoxicity

Indexed keywords

CREATININE; LEAD;

ADULT; ARTICLE; BODY BURDEN; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESSENTIAL HYPERTENSION; GOUT; HUMAN; HYPERTENSION; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029797705     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027667     Document Type: Article

References (30)

1. Lanceraux E. Néphrite et arthrite saturnines: coincidence de ces affections: parallèle avec la nephrite et l'arthrite goutteuses. Arch Gen Med Par 1881; 6: 641-653
2. Nuyts GD, Daelemans RA, Jorens PG, Elseviers MM, Van de Vyver FL, De Broe ME. Does lead nephropathy play a role in the development of chronic renal disease? Nephrol Dial Transplant 1991; 6: 307-315
3. Ritz E, Mann J, Stoeppler M. Lead and the kidney. Adv Nephrol 1988; 17: 241-274
4. Behringer D, Craswell P, Mohl C, Stoeppler M, Ritz E. Urinary lead excretion in uremic patients. Nephron 1986; 42: 323-329
5. Koster J, Erhardt A, Stoeppler M, Mohl C, Ritz E. Mobilizable lead in patients with chronic renal failure. Eur J Clin Invest 1989; 19: 228-233
6. Radosevic Z, Saric M, Beritic T, Knezevic J. The kidney in lead poisoning. Br J Ind Med 1961; 18: 222-230
7. Lilis R, Gavrilescu N, Nestorescu B, Dumitrui C, Roventa A. Nephropathy in chronic lead poisoning. Br J Ind Med 1968; 25: 196-202
8. Wedeen RP, Mallik DK, Batuman B. Detection and treatment of occupational lead nephropathy. Arch Intern Med 1979; 139: 53-57
9. Hong Cd, Hanenson IB, Lerner S, Hammond PB, Pesce AJ, Pollak VE. Occupational exposure to lead: effects on renal function. Kidney Int 1980; 18: 489-494
10. Greenberg A, Parkinson DK, Fetterolf DE et al. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch Environ Health 1986; 41: 69-76
11. Pinto de Almeida AR, Carvalho FM, Spinola AG, Rocha H. Renal dysfunction in Brazilian lead workers. Am J Nephrol 1987; 7: 455-458
12. Lin JL, Lim PS. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension? J Hum Hypertens 1994; 8: 495-500
13. Lin JL, Huang PT. Body lead stores and urate excretion in men with chronic renal disease. J Rheumatol 1994; 21: 705-709
14. Nuyts GD, Elseviers MM, D'Haese PC, De Broe ME. Renal dysfunction and lead exposure. Am J Nephrol 1989; 9: 85-86
15. Buchet JP, Roels H, Bernard A, Lauwerys R. Assessment of renal function of workers exposed to inorganic lead, cadmium or mercury vapor. J Occup Med 1980; 22: 741-750
16. Buchet JP, Roels H, Bernard A, Lauwerys R. Assessment of renal function of workers simultaneously exposed to inorganic lead and cadmium. J Occup Med 1981; 23: 348-352
17. Van de Vyver FL, D'Haese PC, Visser WJ et al. Bone lead in dialysis patients. Kidney Int 1988; 33: 601-607
18. Emmerson BT. Chronic lead nephropathy: the diagnostic use of calcium EDTA and the association with gout. Aust NZ J Med 1973; 12: 310-24
19. Batuman V, Landy E, Maesaka JK, Wedeen RP. Contribution of lead to hypertension with renal impairment. N Engl J Med 1983; 309: 17-21
20. Arroyo M, Martín-Serrano J, Pérez Cuadrado S. Determinación analítica conjunta de plomo y cadmio en viales de Resistocell. Med y Seg del Trabajo 1989; 36: 13-20
21. Berlin A, Schaller KH. European standardized method for the determination of δ-aminolevulinic acid dehydrase activity in blood. J Clin Chem Clin Biochem 1974; 12: 389-390
22. Piomelli S. Free erythrocyte protoporphyrin in the detection of undue absorption of Pb and of Fe deficiency. Clin Chem 1977; 23: 264-269
23. Colleoni N, D'Amico G. Chronic lead accumulation as a possible cause of renal failure in gouty patients. Nephron 1986; 44: 32-35
24. Lin JL, Lim PS. Elevated blood lead in chinese patients without occupational lead exposure. Miner Electrolyte Metab 1992; 18(1): 1-5
25. Staessen JA, Lauwerys RR, Buchet JP et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992; 327: 151-156
26. Batuman V, Maesaka JK, Haddad B, Tepper E, Landy E, Wedeen RP. The role of lead in gout nephropathy. N Engl J Med 1981; 26: 520-523
27. Bianchi C. Measurement of the glomerular filtration rate. Progr Nucl Med 1972; 2: 21-53
28. Craswell PW, Price J, Boyle PD, Healzewood VJ, Baddeley HM, Lloyd BJ. Chronic renal failure with gout: a marker of chronic lead poisoning. Kidney Int 1984; 26: 319-323
29. Aviv A, John E, Bernstein J, Goldsmith DI, Spitzer A. Lead intoxication during development: its late effects on kidney function and blood pressure. Kidney Int 1980; 17: 430-437
30. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med 1989; 320: 684-688